Zacks Small Cap Research on MSN16h
GRCE: FY:25 Second Quarter ResultsGRCE READ THE FULL GRCE RESEARCH REPORT Grace Therapeutics, Inc (NASDAQ:GRCE) reported financial results and achievements for its fiscal second quarter ending September 30th, 2024 on November 13th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback